Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 7:2020:4587459.
doi: 10.1155/2020/4587459. eCollection 2020.

Probiotics in the Management of Atopic Dermatitis for Children: A Case-Based Review

Ashila Putri Disamantiaji  1 , Endang Farihatul Izza  1 , Muhamad Faza Soelaeman  1 , Tannia Sembiring  1 , Melva Louisa  2
Affiliations
Review

Probiotics in the Management of Atopic Dermatitis for Children: A Case-Based Review

Ashila Putri Disamantiaji et al. Dermatol Res Pract. .

Abstract

Background: Atopic dermatitis or eczema is one of the most common dermatologic problems, especially in children. Several studies have hypothesized that alteration of gut-colonizing microbes might have induced and conditioned the development of the disease. Thus, modulation of microbial diversity and abundance might help alleviate symptoms and conditions for patients. Given the ability of commensal and symbiotic microorganisms in modulating the immune system, probiotics administration has been studied in previous research in the management of eczema. However, until today, there are conflicting results between studies making inconclusive recommendations towards probiotics supplementation in the management of atopic dermatitis. This case-based review was done to assess and evaluate the therapeutic efficacy of probiotics supplementation in the management of eczema in children.

Method: An electronic database search was conducted in PubMed-NCBI, Cochrane, EBSCO, ProQuest, and SCOPUS in March 2020. Individual studies and reviews were then gathered for screening using predetermined inclusion and exclusion criteria. The included studies were then critically appraised for their validity and importance.

Result: A total of 5 studies, all of which were RCTs, were included in this review. Out of all the studies included, 4 showed no clinically significant improvements in using probiotics in the management of eczema in children as they did not pass the minimal clinically important difference (MCID) of eczema severity as determined by SCORAD (SCORing Atopic Dermatitis).

Conclusion: Supplementation of probiotics in the management of eczema in children does not show a clinically relevant difference vs. standard treatment in reducing eczema severity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flowchart describing the steps of study selection.
See this image and copyright information in PMC

References

    1. Intercollegiate Guidelines Network S. Management of atopic eczema in primary care Scottish intercollegiate guidelines network. March 2011. https://www.sign.ac.uk/assets/sign125.pdf.
    1. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Annals of Nutrition and Metabolism. 2015;66(1):8–16. doi: 10.1159/000370220. - DOI - PubMed
    1. Reed B., Blaiss M. S. The burden of atopic dermatitis. Allergy and Asthma Proceedings. 2018;39(6):406–410. doi: 10.2500/aap.2018.39.4175. - DOI - PubMed
    1. Chopra R., Vakharia P. P., Sacotte R., et al. Relationship between EASI and SCORAD severity assessments for atopic dermatitis. Journal of Allergy and Clinical Immunology. 2017;140(6):1708–1710. doi: 10.1016/j.jaci.2017.04.052. - DOI - PMC - PubMed
    1. Guttman‐Yassky E. , Waldman A., Ahluwalia J., Ong P. Y., Eichenfield L. Atopic dermatitis: pathogenesis. Seminars in Cutaneous Medicine and Surgery. 2017;36(3):100–103. doi: 10.12788/j.sder.2017.036. - DOI - PubMed

LinkOut - more resources